Navigation Links
Flu Viruses Gaining Resistance, Study Confirms
Date:12/7/2010

TUESDAY, Dec. 7 (HealthDay News) -- Certain influenza virus strains are developing increasing drug resistance and greater ability to spread, a new study warns.

American and Canadian researchers confirmed that resistance to the two approved classes of antiviral drugs can occur in several ways and said this dual resistance has been on the rise over the past three years.

The team analyzed 28 seasonal H1N1 influenza viruses that were present in five countries from 2008 to 2010 and were resistant to both M2 blockers (adamantanes) and neuraminidase inhibitors (NAIs), including oseltamivir and zanamivir.

The researchers found that additional antiviral resistance can rapidly develop in a previously single-resistant influenza virus through mutation, drug response, or gene exchange with another virus.

The study also found that the proportion of tested viruses with dual resistance increased from 00.6 percent in 2007-08 to 1.5 percent in 2008-09 and 28 percent in 2009-10.

The findings are published online Dec. 7 in advance of print publication Jan. 1 in the Journal of Infectious Diseases.

"Because only two classes of antiviral agents are approved, the detection of viruses with resistance to drugs in both classes is concerning," study author Dr. Larisa Gubareva, of the U.S. Centers for Disease Control and Prevention, said in a journal news release.

"If circulation of these viruses with dual resistance becomes more widespread among any of the predominant circulating influenza A viruses, treatment options will be extremely limited," she added. "New antiviral agents and strategies for antiviral therapy are likely to be necessary in the future."

Another study in the same issue of the journal examined an outbreak of oseltamivir-resistant pandemic H1N1 influenza in a hematology unit in a British hospital. The researchers concluded "that oseltamivir may not be the frontline drug of choice in hematology patients, and zanamivir may prove to be more beneficial."

In an editorial accompanying the two studies, experts said increased monitoring and creative prevention and treatment choices will be needed as unpredictable and antiviral-resistant influenza viruses continue to appear.

With only two classes of antiviral drugs approved for use in most countries, future research should focus on the effectiveness of zanamivir and combination antiviral therapy and the development of new types of antiviral drugs, wrote Dr. Frederick G. Hayden, of the University of Virginia School of Medicine, and Dr. Menno D. de Jong, of the University of Amsterdam in the Netherlands.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about influenza.

-- Robert Preidt

SOURCE: Journal of Infectious Diseases, news release, Dec. 7, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
2. Targeting hit-and-run cancer viruses
3. Researchers find function of proteins that can enhance the progression of viruses and cancer cells
4. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
5. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
6. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
7. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
8. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
9. UBC graduate student finds a start/stop switch for retroviruses
10. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
11. Gaining Weight Raises Risk of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flu Viruses Gaining Resistance, Study Confirms
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization declared the ... four million Zika-related cases in the Americas within the next year. Lyme disease is ... per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... City Convention Center at 10 North Broadway Avenue, will be an educational and ... relevant, practical instruction in the management of chronic pain. , Oklahoma is in ...
(Date:3/23/2017)... ... March 23, 2017 , ... March is National Kidney Month – the perfect ... comes to maintaining good health. Every day, two kidneys filter about 120 to 150 ... of your blood, eliminating waste, regulating fluid levels and blood pressure, supporting bone health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of ... manage stress and anxiety. , “Buzzies change the way we interact with stress ... Buzzies. , Since its launch date in December 2016, The TouchPoint Solution has sold ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017 Research and Markets has announced the ... to their offering. ... The global capillary electrophoresis market to grow at a CAGR ... Global Capillary Electrophoresis Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:3/23/2017)... , March 23, 2017  Drug diversion is ... misuse and deadly overdoses. A new oral fluid ... www.cordantsolutions.com , reports more detailed and actionable ... can potentially improve therapy adherence, patient safety, and ... Cordant Comprehensive Oral fluid Rx Evaluation (CORE) system ...
(Date:3/23/2017)...  A new genetic test has been discovered ... who carry HLA-B*15:02 and who are ... deadly side effect of certain medications used to ... HLA-B*15:02 is strongly associated with life-threatening severe ... toxic epidermal necrolysis in patients treated with carbamazepine ...
Breaking Medicine Technology: